0001758829-19-000001.txt : 20190913 0001758829-19-000001.hdr.sgml : 20190913 20190913143509 ACCESSION NUMBER: 0001758829-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190913 DATE AS OF CHANGE: 20190913 EFFECTIVENESS DATE: 20190913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Brava Diagnostics, Inc. CENTRAL INDEX KEY: 0001758829 IRS NUMBER: 831771732 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-348814 FILM NUMBER: 191092348 BUSINESS ADDRESS: STREET 1: 5603 ARAPAHOE AVENUE STREET 2: SUITE 1 CITY: BOULDER STATE: CO ZIP: 80303 BUSINESS PHONE: (661) 993-4085 MAIL ADDRESS: STREET 1: 5603 ARAPAHOE AVENUE STREET 2: SUITE 1 CITY: BOULDER STATE: CO ZIP: 80303 D 1 primary_doc.xml X0708 D LIVE 0001758829 Brava Diagnostics, Inc. 5603 ARAPAHOE AVENUE SUITE 1 BOULDER CO COLORADO 80303 (661) 993-4085 DELAWARE None None Corporation true 2018 Byron Hewett 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Executive Officer Director Promoter Chris Myatt 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Robert Silverman 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Director Promoter Carrie Mulherin 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Promoter David Okrongly 5603 Arapahoe Avenue Suite 1 Boulder CO COLORADO 80303 Promoter Biotechnology Decline to Disclose 06b false 2019-08-29 false true true Convertible promissory notes convertible into equity securities of the Issuer and the equity securities to be issued upon such conversion false 0 1500000 250000 1250000 false 3 0 0 0 false Brava Diagnostics, Inc. Byron Hewett Byron Hewett Chief Executive Officer 2019-09-09